Gynecology Surgical Instruments Market Size & Share Analysis - Growth Trends and Forecast (2027 - 2032)

The Gynecology Surgical Instruments Market is Segmented by Product Type (Forceps, Scissors, and More), Usability (Reusable Instruments, Disposable and Single-Use Instruments), Application (Laparoscopy, Hysteroscopy, and More), End-User (Hospitals, Gynecology Clinics and Specialty Clinics, and More), and Geography (North America, Europe, Asia-Pacific, Middle East and Africa, South America). Market Forecasts are in Value (USD).

Gynecology Surgical Instruments Market Size and Share

Gynecology Surgical Instruments Market Size
Image © Mordor Intelligence. Reuse requires attribution under CC BY 4.0.

Gynecology Surgical Instruments Market Analysis by Mordor Intelligence

The Gynecology Surgical Instruments Market size is expected to increase from USD 3.09 billion in 2026 to USD 3.28 billion in 2027 and reach USD 4.65 billion by 2032, growing at a CAGR of 7.22% over 2027-2032.

Rising gynecological cancer incidence and the continuing burden of benign conditions are increasing the need for diagnostic and surgical care. The gynecology surgical instruments market is also changing as laparoscopic, robotic, and office-based procedures replace a portion of open and inpatient care. Providers are balancing reusable equipment against single-use products based on sterilization capacity, procedure time, and infection-control needs. Larger suppliers can extend their positions through broad portfolios and regulatory resources, while specialized suppliers can serve procedure-specific needs. The gynecology surgical instruments market has additional room for expansion, as women’s health screening, surgical training, and outpatient infrastructure are improving.

Key Report Takeaways

  • By product type, forceps held 37.15% of the gynecology surgical instruments market share in 2026, while trocars and access instruments are forecast to grow at a 7.74% CAGR through 2032.
  • By usability, reusable instruments held 51.24% of the gynecology surgical instruments market share in 2026, while disposable and single-use instruments are expected to grow at an 8.15% CAGR through 2032.
  • By application, laparoscopy accounted for 38.21% of the gynecology surgical instruments market in 2026, while hysteroscopy is forecast to grow at a 9.22% CAGR through 2032.
  • By end-user, hospitals accounted for 42.53% of the gynecology surgical instruments market in 2026, while gynecology and specialty clinics are expected to grow at an 8.63% CAGR through 2032.
  • By geography, North America accounted for 47.33% of the gynecology surgical instruments market in 2026, while Asia-Pacific is projected to grow at a 10.35% CAGR through 2032.

Note: Market numbers in this report are based on Mordor Intelligence's proprietary estimation framework, which combines nine months of actuals with Q4 projections for base year 2026.

Gynecology Surgical Instruments Market Segment Analysis

By Product Type:

Forceps Lead Volume While Trocars Scale with Minimally Invasive Uptake

Forceps held 37.15% of the gynecology surgical instruments market share in 2026. Their position reflects use across laparoscopic, hysteroscopic, and open procedures. Biopsy, grasping, and tenaculum forceps each serve distinct clinical requirements. Trocars and access instruments are forecasted to grow at a 7.74% CAGR through 2032. Each laparoscopic or robotic procedure can require 2 to 4 trocar insertions. Higher procedure counts, therefore, increase demand for access products. Clinical support for minimally invasive hysterectomy strengthens this pattern.

Scissors and needle holders remain linked to surgeon technique and suturing preferences. Vaginal speculums are moving toward single-use plastic versions in ambulatory and clinic settings. This transition reflects infection-control requirements and simpler outpatient workflows. Dilators and curettes continue to support dilation and curettage procedures and cervical preparation. The product mix in the gynecology surgical instruments industry is increasingly shaped by compatibility with these installed platforms.

Need more granular breakdown of segment shares?

Get tailored market insights for your requirements.

Gynecology Surgical Instruments Market Share by Product Type, 2026
Image © Mordor Intelligence. Reuse requires attribution under CC BY 4.0.
Gynecology Surgical Instruments Market Share by Product Type, 2026

By Usability:

Reusable Instruments Anchor Share, but Disposables Reframe the Total-Cost Calculus

Reusable instruments accounted for 51.24% of revenue in 2026. Large hospitals can spread reprocessing costs over a high volume of procedures. The gynecology surgical instruments market size for reusable products remains supported by centralized sterilization departments. In a hysterectomy trial, a disposable energy device reduced total procedural cost despite its higher unit price. Buyers must therefore assess equipment economics at the procedure level.

Disposable and single-use products are projected to grow at an 8.15% CAGR through 2032. Infection-control requirements and ambulatory center workflows support this expansion. Clinics and fertility centers may lack the capacity to reprocess complex instruments. CooperSurgical acquired Obp Surgical and its ONETRAC single-use platform for USD 100 million in August 2024. Quality and sterilization requirements remain relevant for suppliers serving both product categories.

By Application:

Laparoscopy Anchors Procedure Volume While Hysteroscopy Rewrites Site Economics

Laparoscopy accounted for 38.21% of application revenue in 2026. It is used for hysterectomy, ovarian cystectomy, endometriosis excision, and tubal ligation. Clinical guidance supports laparoscopic approaches when they are feasible for the patient and procedure. This established procedural base supports stable instrument demand across the gynecology surgical instruments market. Hysteroscopy is forecasted to record the fastest application growth at a 9.22% CAGR through 2032. Single-use hysteroscopes can avoid the need for reprocessing equipment in clinics. Office-based diagnostics can also reduce dependence on hospital operating rooms.

Dilation and curettage remains used in incomplete miscarriage management and uterine polyp removal. Its relative contribution may decline where hysteroscopy manages conditions once addressed through dilation and curettage. Colposcopy and cervical biopsy instruments benefit from national screening programs. The gynecology surgical instruments market thus relies on both diagnostic access and procedural capability.

Segment this market the way your business does.

Get tailored market insights for your requirements.

Gynecology Surgical Instruments Market Share by Application, 2026
Image © Mordor Intelligence. Reuse requires attribution under CC BY 4.0.
Gynecology Surgical Instruments Market Share by Application, 2026

By End-User:

Hospitals Retain Scale Advantage as Specialty Clinics Lead Growth Rate

Hospitals held 42.53% of end-user revenue in 2026. They manage high-acuity care, including gynecologic oncology surgery and complex robotic procedures. These cases often require more extensive instrument ecosystems and higher spending per procedure. Hospitals retain centralized sterile processing capabilities for reusable portfolios. Large facilities can also evaluate new robotic-compatible instruments through formal clinical and purchasing processes. This sustains demand for broad portfolios from established device suppliers.

Gynecology and specialty clinics are expected to grow at an 8.63% CAGR through 2032. These providers perform diagnostic hysteroscopy, colposcopy, cervical biopsy, and office-based endometrial ablation. Ambulatory surgery centers can offer lower facility costs for eligible laparoscopic and hysteroscopic procedures. Academic institutions remain important for robotic compatibility studies and early clinical evaluation. Their assessments can support wider adoption after products enter routine care. The gynecology surgical instruments industry must address different purchasing needs across these end-user settings.

Geography Analysis

North America

North America held 47.33% of the gynecology surgical instruments market share in 2026. High procedure volumes and concentrated group purchasing support regional demand. ACOG guidance favors minimally invasive gynecological surgery where clinically appropriate. The United States accounts for most regional revenue. Canada supports steady, cost-focused reusable instrument purchasing through its publicly funded health system. Mexico provides an incremental source of demand through private hospitals and medical tourism. Regulatory review pathways in the United States influence the pace of device launches.

Europe

Europe is the second-largest regional market. Germany and the United Kingdom represent the largest national demand concentrations in the region. University hospital networks in Germany are adopting bipolar vessel-sealing technology for laparoscopic hysterectomy. This can shorten procedures and reduce open-conversion risk. The EU Medical Device Regulation raises requirements for biocompatibility and sterilization validation. These requirements can raise maintenance costs for mid-tier instrument portfolios. France, Italy, and Spain are expanding ambulatory hysteroscopy as payers shift diagnostic care from hospital operating rooms. Eastern Europe offers further opportunities as health infrastructure is upgraded.

Asia-Pacific, the Middle East and Africa, and South America

Asia-Pacific is projected to expand at a 10.35% CAGR through 2032, the fastest regional rate in the gynecology surgical instruments market. China is expanding minimally invasive surgical training beyond tier-1 cities. India’s private hospital sector adds procedure capacity and access to gynecological care. Japan’s aging female population supports demand for uterine and ovarian cancer surgery. South Korea and Australia have advanced technology adoption patterns. The Middle East and Africa benefit from private hospital expansion in Gulf Cooperation Council countries. South America draws demand from Brazil and Argentina. These regions remain smaller contributors but offer longer-term procurement opportunities as women’s health infrastructure develops.

Gynecology Surgical Instruments Market Growth Rate by Region
Image © Mordor Intelligence. Reuse requires attribution under CC BY 4.0.

Competitive Landscape

Market Concentration

Gynecology Surgical Instruments Market Concentration
Image © Mordor Intelligence. Reuse requires attribution under CC BY 4.0.

The gynecology surgical instruments market is moderately consolidated. Medtronic, Olympus, KARL STORZ, Johnson & Johnson, and B. Braun Melsungen compete through broad surgical instrument portfolios. CooperSurgical, Hologic, and LiNA Medical retain positions in procedure-specific categories and end-user niches. Broad portfolios can support contracts across multiple gynecological procedures. Specialized suppliers can compete through focused clinical use cases and accessible product offerings. Regulatory documentation and post-market surveillance capabilities favor better-resourced suppliers. The EU Medical Device Regulation can increase compliance requirements for reusable and single-use devices. This can make expansion harder for smaller manufacturers with limited regulatory resources.

Robotic platform expansion is increasing competition for compatible instruments. CMR Surgical submitted a 510(k) application for Versius Plus in benign gynecology in April 2026. The company reported that the Versius family had treated more than 45,000 patients globally at the time of filing. Medtronic also submitted filings to expand Hugo into gynecologic specialties in June 2026. These systems can increase demand for platform-specific access, grasping, and energy products. Suppliers with robotic-compatible products can gain from replacement cycles within installed systems.

Portfolio expansion remains an important strategic option. Hologic completed its acquisition of Gynesonics for USD 350 million in January 2025. The Sonata system added a transcervical fibroid treatment platform to Hologic’s portfolio. In July 2026, Medtronic announced Touch Surgery Aide and its FDA-cleared Instrument Exit Point application for Hugo procedures. The platform operates in more than 1,500 operating rooms worldwide. These moves show how acquisitions, robotics, and real-time surgical computing can strengthen competitive positions.

Gynecology Surgical Instruments Industry Leaders

  1. CooperSurgical Inc.

  2. Hologic, Inc.

  3. KARL STORZ GmbH & Co. KG

  4. Olympus Corporation

  5. Johnson & Johnson

  6. *Disclaimer: Major Players sorted in no particular order

Gynecology Surgical Instruments Market Companies Covered in this Report

  • Aesculap
  • B. Braun
  • Boston Scientific
  • Conmed
  • Cook Group
  • The Cooper Companies
  • Gynesonics, Inc.
  • Hologic
  • Johnson & Johnson
  • Karl Storz
  • LiNA Medical ApS
  • MedGyn Products
  • Medtronic
  • Olympus
  • Richard WOLF GmbH
  • Sklar Surgical Instruments
  • Smiths Group
  • STERIS
  • Stryker
  • Tetra Surgical Industries

Recent Industry Developments in Gynecology Surgical Instruments Market

  • June 2026: Medtronic submitted 510(k) filings to the United States FDA to expand the Hugo RAS system into gynecologic surgical specialties. The filing follows completed enrollment in the Embrace Gynecology IDE clinical study, 70 patients across 5 United States hospitals, and was accompanied by a concurrent 510(k) submission for the LigaSure RAS Maryland instrument.
  • April 2026: CMR Surgical submitted a 510(k) premarket notification to the United States FDA for the Versius Plus Surgical Robotic System for benign gynecology procedures, including total hysterectomy, oophorectomy, and salpingectomy. The Versius family had treated more than 45,000 patients globally at the time of submission, with gynecological procedures representing a large proportion of recorded cases.

Table of Contents for Gynecology Surgical Instruments Industry Report

1. Introduction

  • 1.1 Study Assumptions and Market Definition
  • 1.2 Scope of the Study

2. Research Methodology

3. Executive Summary

4. Market Landscape

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Rising Burden of Gynecological Disorders and Cancers
    • 4.2.2 Expansion of Minimally Invasive Gynecological Procedures
    • 4.2.3 Shift Toward Office-Based and Ambulatory Surgery
    • 4.2.4 Women's-Health Infrastructure and Screening Investment
    • 4.2.5 Disposable and Single-Use Instrument Adoption
    • 4.2.6 AI-Enabled Visualization and Precision Instrumentation
  • 4.3 Market Restraints
    • 4.3.1 High Capital, Reprocessing, and Procedure Costs
    • 4.3.2 Shortage of Trained Gynecological Surgical Personnel
    • 4.3.3 Divergent Regulatory and Reimbursement Requirements
    • 4.3.4 Instrument Waste and Sustainability Trade-offs
  • 4.4 Supply Chain Analysis
  • 4.5 Regulatory Landscape
  • 4.6 Technological Outlook
  • 4.7 Porter's Five Forces Analysis
    • 4.7.1 Threat of New Entrants
    • 4.7.2 Bargaining Power of Suppliers
    • 4.7.3 Bargaining Power of Buyers
    • 4.7.4 Threat of Substitutes
    • 4.7.5 Competitive Rivalry

5. Market Size & Growth Forecasts (Value, USD)

  • 5.1 By Product Type
    • 5.1.1 Forceps
    • 5.1.2 Scissors
    • 5.1.3 Trocars and Access Instruments
    • 5.1.4 Needle Holders
    • 5.1.5 Vaginal Speculums
    • 5.1.6 Dilators and Curettes
    • 5.1.7 Other Product Types
  • 5.2 By Usability
    • 5.2.1 Reusable Instruments
    • 5.2.2 Disposable/Single-Use Instruments
  • 5.3 By Application
    • 5.3.1 Laparoscopy
    • 5.3.2 Hysteroscopy
    • 5.3.3 Dilation and Curettage
    • 5.3.4 Colposcopy and Cervical Biopsy
    • 5.3.5 Other Applications
  • 5.4 By End-User
    • 5.4.1 Hospitals
    • 5.4.2 Gynecology Clinics and Specialty Clinics
    • 5.4.3 Ambulatory Surgery Centers
    • 5.4.4 Fertility and Reproductive-Health Centers
    • 5.4.5 Other End-Users (Academic and Research Institution, and More)
  • 5.5 By Geography
    • 5.5.1 North America
    • 5.5.1.1 United States
    • 5.5.1.2 Canada
    • 5.5.1.3 Mexico
    • 5.5.2 Europe
    • 5.5.2.1 Germany
    • 5.5.2.2 United Kingdom
    • 5.5.2.3 France
    • 5.5.2.4 Italy
    • 5.5.2.5 Spain
    • 5.5.2.6 Rest of Europe
    • 5.5.3 Asia-Pacific
    • 5.5.3.1 China
    • 5.5.3.2 Japan
    • 5.5.3.3 India
    • 5.5.3.4 Australia
    • 5.5.3.5 South Korea
    • 5.5.3.6 Rest of Asia-Pacific
    • 5.5.4 Middle East and Africa
    • 5.5.4.1 GCC
    • 5.5.4.2 South Africa
    • 5.5.4.3 Rest of Middle East and Africa
    • 5.5.5 South America
    • 5.5.5.1 Brazil
    • 5.5.5.2 Argentina
    • 5.5.5.3 Rest of South America

6. Competitive Landscape

  • 6.1 Market Concentration
  • 6.2 Market Share Analysis
  • 6.3 Company Profiles (includes Global level Overview, Market level overview, Core Segments, Financials as available, Strategic Information, Market Rank/Share for key companies, Products & Services, Recent Developments)
    • 6.3.1 Aesculap AG
    • 6.3.2 B. Braun Melsungen AG
    • 6.3.3 Boston Scientific Corporation
    • 6.3.4 CONMED Corporation
    • 6.3.5 Cook Medical LLC
    • 6.3.6 CooperSurgical Inc.
    • 6.3.7 Gynesonics, Inc.
    • 6.3.8 Hologic, Inc.
    • 6.3.9 Johnson & Johnson
    • 6.3.10 KARL STORZ GmbH & Co. KG
    • 6.3.11 LiNA Medical ApS
    • 6.3.12 MedGyn Products, Inc.
    • 6.3.13 Medtronic plc
    • 6.3.14 Olympus Corporation
    • 6.3.15 Richard WOLF GmbH
    • 6.3.16 Sklar Surgical Instruments
    • 6.3.17 Smith & Nephew plc
    • 6.3.18 STERIS plc
    • 6.3.19 Stryker Corporation
    • 6.3.20 Tetra Surgical Industries

7. Market Opportunities & Future Outlook

  • 7.1 White-space & Unmet-need Assessment

Global Gynecology Surgical Instruments Market Report Scope

According to the report’s scope, the gynecology surgical instruments market refers to the industry supplying specialized instruments used in gynecological surgeries such as hysterectomy, laparoscopy, cesarean section, and endoscopy. It includes products like forceps, scissors, speculums, retractors, and laparoscopic devices, designed to ensure precision, safety, and efficiency in women’s health procedures.

The gynecology surgical instruments market is segmented into product type, usability, application, end-user, and geography. By product type, the market is segmented into forceps, scissors, trocars and access instruments, needle holders, vaginal speculums, dilators and curettes, and other product types. By usability, the market is segmented into reusable instruments and disposable and single-use instruments. By application, the market is segmented into laparoscopy, hysteroscopy, dilation and curettage, colposcopy and cervical biopsy, and other applications. By end-user, the market is segmented into hospitals, gynecology clinics and specialty clinics, ambulatory surgery centers, fertility and reproductive-health centers, and academic and research institutions. By geography, the market is segmented into North America, Europe, Asia-Pacific, the Middle East and Africa, and South America. The report also covers the estimated market sizes and trends for 17 countries across major regions globally. The report offers values (USD) for all the above segments.  

Segmentation Overview

By Product Type
Gynecology Surgical Instruments Market segmentation breakdown
Forceps
Scissors
Trocars and Access Instruments
Needle Holders
Vaginal Speculums
Dilators and Curettes
Other Product Types
By Usability
Gynecology Surgical Instruments Market segmentation breakdown
Reusable Instruments
Disposable/Single-Use Instruments
By Application
Gynecology Surgical Instruments Market segmentation breakdown
Laparoscopy
Hysteroscopy
Dilation and Curettage
Colposcopy and Cervical Biopsy
Other Applications
By End-User
Gynecology Surgical Instruments Market segmentation breakdown
Hospitals
Gynecology Clinics and Specialty Clinics
Ambulatory Surgery Centers
Fertility and Reproductive-Health Centers
Other End-Users (Academic and Research Institution, and More)
By Geography
Gynecology Surgical Instruments Market segmentation breakdown
North America United States
Canada
Mexico
Europe Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle East and Africa GCC
South Africa
Rest of Middle East and Africa
South America Brazil
Argentina
Rest of South America
Gynecology Surgical Instruments Market segmentation breakdown
By Product Type Forceps
Scissors
Trocars and Access Instruments
Needle Holders
Vaginal Speculums
Dilators and Curettes
Other Product Types
By Usability Reusable Instruments
Disposable/Single-Use Instruments
By Application Laparoscopy
Hysteroscopy
Dilation and Curettage
Colposcopy and Cervical Biopsy
Other Applications
By End-User Hospitals
Gynecology Clinics and Specialty Clinics
Ambulatory Surgery Centers
Fertility and Reproductive-Health Centers
Other End-Users (Academic and Research Institution, and More)
By Geography North America United States
Canada
Mexico
Europe Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle East and Africa GCC
South Africa
Rest of Middle East and Africa
South America Brazil
Argentina
Rest of South America

Key Questions Answered in the Report

What is the forecast growth rate through 2032?

The gynecology surgical instruments market is forecasted to grow from USD 3.09 billion in 2026 to USD 3.28 billion in 2027, and to reach USD 4.65 billion by 2032, at a 7.22% CAGR through 2032.

Which product type has the largest revenue share?

Forceps led product revenue with a 37.15% share in 2026.

Which application is expanding fastest?

Hysteroscopy is projected to grow at a 9.22% CAGR through 2032 as more diagnostic procedures shift into office-based settings.

Which region is growing fastest?

Asia-Pacific is forecasted to expand to 10.35% CAGR through 2032, supported by training, infrastructure, and access improvements.

Page last updated on: